Banc of California, Inc. is a financial holding company that, through its subsidiary Banc of California, National Association, delivers a full spectrum ...
This article from Investing.com announces a Form 4 filing for Banc of California Inc., relating to transactions on July 10. The content includes the headline and a repetition of the headline, alongside financial market data and unrelated news, but provides no specific details about the Form 4 itself.
Banc of California (NYSE: BANC) has granted Joseph J. Rice, SR EVP AND VICE CHAIRMAN, 68,114 stock and performance units. Rice received 18,114 restricted stock units vesting annually over three years starting July 31, 2027, and 50,000 performance-based restricted stock units. These performance units are contingent on the company's common stock achieving a twenty-day Volume-Weighted Average Price of $28.73 per share by May 23, 2028, and Rice's continued service.
This article reports on a Form 4 filing for Banc of California Inc. on July 10. Such filings typically disclose transactions by company insiders, providing transparency into their stock movements. The brief piece indicates that this information was published by Investing.com.
Banc of California (BANC) stock reflects the bank's ongoing strategic transformation in regional lending and deposits, emphasizing capital strength, loan quality, and positioning within an evolving regulatory and interest-rate environment. The bank focuses on serving local businesses and households with traditional banking products, disciplined lending, and robust deposit gathering, while competing against national institutions and digital platforms. Investors are advised to consider the bank's balance sheet, earnings drivers, operating efficiency, and alignment with sector best practices for resilience through credit and rate cycles.
Allotera Therapeutics, formerly Wugen, has successfully closed a $35 million financing round, combining equity and venture debt, to advance its off-the-shelf CAR-T cell therapies for T-cell cancers. The company has also rebranded to Allotera to reflect its refined focus, with the capital primarily supporting the pivotal T-RRex clinical trial for Soficabtagene Geleucel (Sofi-cel) in relapsed or refractory T-ALL/T-LBL. This funding increases Allotera's total capital raised to $150 million and aims to address critical unmet needs in aggressive T-cell malignancies.
This article from Investing.com announces a Form 4 filing for Banc of California Inc., relating to transactions on July 10. The content includes the headline and a repetition of the headline, alongside financial market data and unrelated news, but provides no specific details about the Form 4 itself.
Banc of California (NYSE: BANC) has granted Joseph J. Rice, SR EVP AND VICE CHAIRMAN, 68,114 stock and performance units. Rice received 18,114 restricted stock units vesting annually over three years starting July 31, 2027, and 50,000 performance-based restricted stock units. These performance units are contingent on the company's common stock achieving a twenty-day Volume-Weighted Average Price of $28.73 per share by May 23, 2028, and Rice's continued service.
This article reports on a Form 4 filing for Banc of California Inc. on July 10. Such filings typically disclose transactions by company insiders, providing transparency into their stock movements. The brief piece indicates that this information was published by Investing.com.
Banc of California (BANC) stock reflects the bank's ongoing strategic transformation in regional lending and deposits, emphasizing capital strength, loan quality, and positioning within an evolving regulatory and interest-rate environment. The bank focuses on serving local businesses and households with traditional banking products, disciplined lending, and robust deposit gathering, while competing against national institutions and digital platforms. Investors are advised to consider the bank's balance sheet, earnings drivers, operating efficiency, and alignment with sector best practices for resilience through credit and rate cycles.
Allotera Therapeutics, formerly Wugen, has successfully closed a $35 million financing round, combining equity and venture debt, to advance its off-the-shelf CAR-T cell therapies for T-cell cancers. The company has also rebranded to Allotera to reflect its refined focus, with the capital primarily supporting the pivotal T-RRex clinical trial for Soficabtagene Geleucel (Sofi-cel) in relapsed or refractory T-ALL/T-LBL. This funding increases Allotera's total capital raised to $150 million and aims to address critical unmet needs in aggressive T-cell malignancies.
Barclays has reiterated its 'Buy' rating for Banc of California (BANC.US), maintaining its target price at $23. This indicates a continued positive outlook from the analytical firm regarding the bank's stock performance.
Wells Fargo has initiated coverage on Banc of California (BANC.US) with a "Buy" rating. The firm has set a target price of $23 for the company's stock, indicating a positive outlook for its performance.
Wells Fargo has reiterated its Overweight rating on Banc of California, reflecting a positive outlook on the company's stock. This maintenance of rating suggests that the firm continues to view Banc of California as an attractive investment within its coverage.
Hodges Capital Management Inc. increased its stake in Banc of California (NYSE:BANC) by 5.6% in the first quarter, now owning 1,462,302 shares. This makes Banc of California the ninth largest position for Hodges Capital Management. Other institutional investors like Vanguard Group Inc. and Invesco Ltd. also increased their holdings, with 86.88% of the stock owned by institutional investors while analysts maintain a "Buy" rating with a $22.56 consensus price target.
The Louisiana State Employees Retirement System has initiated a new position in Banc of California (NYSE:BANC), purchasing 59,500 shares valued at approximately $1.046 million in the first quarter. This move reflects broader institutional interest, with 86.88% of BANC shares held by institutions. Analysts maintain a "Buy" rating for the stock, setting a consensus target price of $22.56, following Banc of California's recent beat on quarterly EPS estimates and its 2.4% dividend yield.
JP Morgan has reiterated its Overweight rating on Banc of California (BANC). This indicates the firm's positive outlook on the bank's stock performance. No specific price target or further details were provided in this brief update.
JPMorgan Chase & Co. has raised its price target for Banc of California (NYSE:BANC) to $24.00 from $22.00, maintaining an "overweight" rating. This new target suggests a potential upside of 16.78% from the stock's current price of $20.55. The bank recently reported better-than-expected Q1 earnings of $0.39 per share, surpassing analyst estimates.
SG Americas Securities LLC significantly increased its stake in Banc of California (NYSE:BANC) by 137.7% in the first quarter, now holding 344,033 shares valued at $6.05 million. Other institutional investors also adjusted their positions, with 86.88% of the stock owned by institutions. Banc of California reported strong Q1 earnings and announced a quarterly dividend, while analysts maintain a "Buy" consensus rating with a target price of $22.31.
Banc of California recently increased its quarterly dividend by 20%, maintaining a conservative payout ratio, which signals management's confidence in the bank's future despite near-term pressures on net interest income. While the dividend hike and share repurchase plan align with broader capital management, investors should consider the bank's concentrated exposure to Southern California real estate. The article suggests evaluating Banc of California's investment narrative, including its projected revenue and earnings growth, against existing risks and analyst forecasts for a comprehensive view.
Banc of California recently increased its quarterly dividend by 20%, maintaining a conservative earnings payout ratio and emphasizing balance sheet resilience. This move, combined with the extension of its share repurchase plan and the subordinated note redemption, signals management's confidence in the bank's prospects despite near-term pressure on net interest income and asset quality concerns regarding Southern California real estate exposure. The article suggests this cautious dividend hike provides a clearer signal about the bank's outlook, reinforcing the narrative that Banc of California aims for durable earnings growth through its California footprint and recent merger.
The article focuses solely on the "Price to earnings forward" metric for Banc of California, Inc. (NYSE: BANC). It provides the current value and changes for this financial indicator but no specific numbers are shown in this content extract. The article appears to be a stub or a section within a larger financial data platform.
This article provides financial information for Banc of California, Inc. Depositary Shares, Series F (BANC/PF), specifically focusing on its "Price to book forward" metric. The content appears to be a snapshot from a financial data platform like TradingView, displaying an overview of the security. It includes the full name of the security and mentions that no trades have occurred for the period displayed.
This article provides financial data for Banc of California, Inc. (BANC) related to its "Price to sales forward" metric. The content appears to be a snapshot from a financial data platform like TradingView, indicating the value and change of this financial ratio. It also lists various ancillary services and information offered by the platform.
The article focuses on the enterprise value to revenue forward of Banc of California, Inc. (BANC) within the financial and regional banks sector. It appears to be a stub or a page with minimal content, likely from a financial data platform like TradingView. The page provides the company name and stock ticker but no specific financial data or analysis.
Banc of California is attracting investor attention due to its focus on lending growth, funding mix, and capital position amidst regional banking sector stress. The bank, which operates in California and trades on the NYSE, concentrates on commercial and consumer banking, with its performance closely watched alongside peers for credit costs, net interest margin, and liquidity. Analysts specifically examine its California market concentration, commercial real estate exposure, and funding cost management.
This page provides news and articles related to Banc of California (BANC) stock. It includes current stock data, an overview of the company's banking services, and a list of recent articles, such as one discussing hidden gem stocks for retirees and another on the Nasdaq Composite.
This article provides a technical analysis of Banc of California Inc (BANC), focusing on its current stock price momentum, support and resistance levels, and key indicators. It notes that BANC currently shows a "Buy" signal based on moving averages and several technical indicators, with its price trading between resistance at 21.51 and support at 19.28. The analysis includes detailed indicator values for MACD, RSI, KDJ, and moving averages, all contributing to an overall positive outlook.
Wall Street analysts have updated their ratings for Banc of California (BANC.US), with price targets generally ranging from $20 to $23. Barclays, UBS, Piper Sandler, and KBW analysts all maintain a buy rating, with slight adjustments in some target prices. D.A. Davidson also maintains a buy rating for the company.
Banc of California Inc (BANC) currently has a weak financial score of 4.65, ranking 375 out of 399 in the Banking Services industry, indicating low operating efficiency. Despite this, the company reported a year-over-year revenue increase of 8.14% to $264.71 million and a significant net profit increase of 42.14% in its latest quarter. The analysis highlights various financial dimensions like Quality of Earnings, Operational Efficiency, Growth Potential, and Shareholder Returns, for which relevant data from the company is largely undisclosed.
Banc of California Inc (BANC) has an institutional shareholding score of 10.00, placing it first in the Banking Services industry. The institutional shareholding proportion is 99.98%, which is a 14.55% decrease quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 0.78% of outstanding shares.
Bridgeway Capital Management LLC significantly increased its stake in Banc of California (NYSE:BANC) by 11.8% during the fourth quarter, now owning 915,325 shares valued at $17.6 million. Other institutional investors also raised their holdings. The bank demonstrated solid financial performance with a market capitalization of $3.06 billion, a P/E ratio of 15.15, positive earnings per share, and recently declared a quarterly dividend of $0.12, reflecting a 2.4% yield.
This article provides a specific financial metric for Banc of California, Inc. (FPB Gettex) focusing on the ratio of demand deposits to total deposits. It appears to be a data point or a section from a larger financial overview on the TradingView platform.
Banc of California (BANC) is presented as a strong investment choice, particularly for income investors, due to its consistent dividend payments and growth. The article highlights its current dividend yield of 2.38%, which exceeds its industry and the S&P 500, along with a 20% year-over-year increase in its annualized dividend. With solid earnings growth projected for 2026 and a favorable payout ratio, BANC is positioned as a compelling dividend play despite a "Hold" rating from Zacks.
Banc of California (BANC) is presented as a strong investment choice due to its consistent dividend payments and growth. The company offers a dividend yield of 2.38%, higher than its industry and the S&P 500, with a 20% increase in its annualized dividend from last year and a 16.61% average annual increase over the past five years. With a payout ratio of 32% and an expected earnings growth of 27.41% for 2026, BANC is considered a compelling dividend play despite currently holding a Zacks Rank of #3 (Hold).
Precision Biosciences (DTIL) has entered into a First Amendment to a Loan and Security Agreement with Banc of California. This information was disclosed in a recent SEC filing. The news was reported by Refinitiv.
Precision BioSciences has amended its loan agreement with Banc of California, extending the maturity date of its term loan from June 30, 2027, to December 31, 2029. This extension aims to provide enhanced financial flexibility for the company. The agreement was signed on June 10, 2026, and is effective immediately.
Verition Fund Management LLC has reduced its stake in Banc of California (NYSE:BANC) by 23.7%, selling 227,226 shares and now holding 732,650 shares valued at $14.1 million. Despite this, analysts maintain a "Buy" rating with an average price target of $22.31, following the bank's beat on quarterly earnings and a 7.9% rise in revenue. Banc of California also announced a quarterly dividend of $0.12 per share.
Banc of California (BANC) is presented as a strong choice for income investors due to its consistent dividend payouts and growth. The stock currently offers a 2.38% dividend yield, higher than its industry and the S&P 500, with a history of increasing its dividend. Analysts predict solid earnings growth for BANC in 2026, further supporting its investment appeal.
Bayview Asset Management LLC decreased its stake in Banc of California (NYSE:BANC) by 27% during the fourth quarter, selling 268,130 shares and retaining 725,000 shares valued at $14.0 million. Despite this reduction, analysts maintain a largely bullish outlook on the stock, with an average "Buy" rating and a consensus price target of $22.31. Banc of California also reported Q4 earnings of $0.39 per share, slightly exceeding estimates, and declared a quarterly dividend of $0.12 per share.
Gator Capital Management LLC significantly reduced its stake in Banc of California (NYSE:BANC) by 16.5% during the fourth quarter, selling 53,655 shares and retaining 271,710 shares valued at approximately $5.24 million. Despite this reduction, Banc of California continues to be a substantial holding for Gator Capital, accounting for 1.1% of its investment portfolio. The article also notes that institutional ownership in Banc of California remains high at 86.88%, with other major investors adjusting their positions.
This article details a Form 144 SEC filing by Banc of California, Inc. (BANC) on June 11, 2026, for a proposed sale of 1,750,000 shares of common stock with an aggregate market value of $34,475,000 through Keefe, Bruyette & Woods, Inc. The securities were acquired via open market purchase on April 23, 2014. The filing indicates a neutral impact and sentiment.
Hodges Capital Management Inc. increased its stake in Banc of California (NYSE:BANC) by 11.3% in the fourth quarter, purchasing an additional 140,911 shares to bring its total holdings to 1,385,290 shares valued at approximately $26.7 million. Banc of California reported better-than-expected quarterly earnings of $0.39 per share, with revenue increasing by 7.9% year-over-year. The bank also declared a quarterly dividend of $0.12 per share, and analysts maintain a consensus "Buy" rating with an average price target of $22.31.
Banc of California, Inc. (NYSE:BANC) is set to go ex-dividend in three days, with a payment of US$0.12 per share, totaling US$0.48 annually for a 2.4% yield. While the company's dividend payout ratio is a modest 32% of earnings, its earnings per share have declined by 16% annually over the last five years. Despite the low payout ratio suggesting affordability post-downturn, the shrinking earnings indicate a need for caution, placing it on a watch-list rather than being a clear buying opportunity.
This article provides an analyst forecast overview for Banc of California (BANC), detailing its market capitalization, volume, and various financial metrics. It also includes information on analyst consensus ratings, price targets, and forward estimates for revenue, EBITDA, EPS, and net income, though all specific values are currently blank.
Banc of California (BANC) has experienced mixed share performance recently but shows strong long-term growth, with its stock up 41% over the past year. Analysts largely view the stock as undervalued, with a fair value of $22.68 compared to its current price of $19.27, largely due to successful integration with Pacific Western Bank. While its P/E ratio is higher than the industry average, its discount to peers and proximity to its fair ratio suggest a modest margin of safety as the company navigates execution and credit risks.
Banc of California (BANC) has experienced mixed share performance, with recent short-term dips offset by stronger gains over the past three months and year, and currently sits at US$19.27 with a market value of US$3.0 billion. The company reported annual revenue of US$1.07 billion and net income of US$207.46 million, both showing positive annual growth, and its valuation suggests it might be undervalued at a fair value of US$22.68, largely due to successful merger integration and anticipated profitability improvements. However, the article notes that this assessment hinges on managing regional commercial real estate exposure and flawless merger execution.
Banc of California (BANC) recently rallied with the broader financial sector, drawing investor attention to its net interest margin and stable deposit costs. While this rally did not fundamentally alter its short-term investment narrative, the bank continues to focus on maintaining net interest income, executing share buybacks, and sustaining its dividend. However, a premium valuation and recent insider selling remain key watchpoints for investors.
Eastern Bank (NASDAQ:EBC) and Banc of California (NYSE:BANC) stocks saw a 3.9% jump after a broader rally in the financial sector, particularly benefiting regional banks. This surge is attributed to widening net interest margins confirmed in Q1 earnings and a "higher-for-longer" interest rate environment, sustaining profitability for the sector. While Banc of California's shares typically aren't highly volatile, this move indicates the market sees the news as significant.
Eastern Bank (NASDAQ:EBC) and Banc of California (NYSE:BANC) stocks saw a significant jump in trading, with both rising 3.9%. This surge followed a broader rally in the financial sector, particularly benefiting regional banks as the Russell 2000 outperformed other indices. The article suggests that a "higher-for-longer" interest rate environment is extending the net interest margin expansion thesis for regional banks.
Banc of California (BANC) saw its shares rally as regional banks gained investor attention due to improving sentiment and stable net interest margins. The bank's investment narrative is centered on strong net interest margin discipline, capital returns, and a growing earnings base. Key drivers include maintaining net interest income momentum and supporting dividends, though risks like its premium valuation, recent insider selling, and potential disappointment in earnings or credit quality remain concerns.
Banc of California Inc (BANC) shares rose 3.8% to $19.34 and are considered 1.2% overvalued according to GuruFocus' GF Value, despite a GF Score of 67/100 indicating above-average quality. Insiders have sold $0.7 million worth of shares in the last three months, suggesting a lack of confidence from within the company. Investors are advised to exercise caution due to the current overvaluation and insider selling.
Regional banks, including Eastern Bank (EBC) and Banc of California (BANC), saw their stocks rise in the afternoon session as the broader financial sector rallied. The Russell 2000's outperformance, coupled with widening net interest margins and weakened expectations for near-term rate cuts, benefited these smaller, domestically focused banks. Although Banc of California's shares are not highly volatile, today's jump indicates the market recognized the significance of these positive sector developments.
The article discusses the net revenue after provisions for Banc of California, Inc. Depositary Shares, specifically those representing a 1/40th interest in a share of 7.75% non-cumulative perpetual preferred stock, Series F (BANC/PF). It highlights that BANC/PF is listed on the Blue Ocean Alternative Trade System and provides information on where to find financials, news, and community related to this specific security.
Multiple analysts have increased their price targets for Banc of California (BANC), with the consensus target now standing at 20.91, representing a 12.95% increase from previous estimates. This upward revision suggests a positive outlook for the company's stock performance.
Warburg Pincus LLC has reported two Rule 144 sales of BANC common stock, totaling 6,557,680 shares for aggregate proceeds of $123,809,857.00. The shares were acquired on November 30, 2023, as merger consideration. This filing indicates a routine resale of previously restricted shares by a private-equity holder, with proceeds going to the seller rather than the issuer.
